BG
MANE

Bellevue Group’s Veradermics Inc MANE Stock Holding History

Bellevue Group’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Buy
+3,468
New +$325K 0.01% 114

Other funds holding MANE

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bellevue Group's MANE Position: Q2 2026 in Review

Bellevue Group opened a new position in Veradermics Inc (MANE) in Q2 2026: 3,468 shares worth $426K. The stake represents 0.01% of the portfolio and ranks #114 among its holdings.

137 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Bellevue Group held 3,468 shares of Veradermics Inc worth $426K as of Q2 2026.
  • Veradermics Inc was a new Bellevue Group position in Q2 2026.
  • Veradermics Inc made up 0.01% of Bellevue Group's portfolio in Q2 2026, its #114 holding.
  • 137 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.